1-20 of 20
leukemia, myelocytic, chronic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular response to imatinib in patients with chronic myeloid leukemia in Tanzania

Clinical Trials & Observations Global Advances
Ahlam Nasser, Ally Hussein, Clara Chamba, Mbonea Yonazi, Rosemary Mushi, Anna Schuh, Lucio Luzzatto
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1403–1411.
https://doi.org/10.1182/bloodadvances.2020002973
Published: 2021
Includes: Supplemental data
Journal Articles

Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression

Clinical Trials & Observations
Richard E. Clark, Jane F. Apperley, Mhairi Copland, Silvia Cicconi
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1102–1109.
https://doi.org/10.1182/bloodadvances.2020003570
Published: 2021
Includes: Supplemental data
Journal Articles

Late molecular recurrences in patients with chronic myeloid leukemia experiencing treatment-free remission

Clinical Trials & Observations
Philippe Rousselot, Clémence Loiseau, Marc Delord, Jean Michel Cayuela, Marc Spentchian
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3034–3040.
https://doi.org/10.1182/bloodadvances.2020001772
Published: 2020
Includes: Supplemental data
Journal Articles

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

Clinical Trials & Observations
Onyee Chan, Chetasi Talati, Leidy Isenalumhe, Samantha Shams, Lisa Nodzon, Michael Fradley, Kendra Sweet, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2020) 4 (3): 530–538.
https://doi.org/10.1182/bloodadvances.2019000268
Published: 2020
Journal Articles

Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia

Clinical Trials & Observations
Shady Adnan Awad, Matti Kankainen, Teija Ojala, Perttu Koskenvesa, Samuli Eldfors, Bishwa Ghimire, Ashwini Kumar, Soili Kytölä, Mahmoud M. Kamel, Caroline A. Heckman, Kimmo Porkka, Satu Mustjoki
Journal: Blood Advances
Blood Adv (2020) 4 (3): 546–559.
https://doi.org/10.1182/bloodadvances.2019000943
Published: 2020
Includes: Supplemental data
Journal Articles

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival

Oscar Brück, Olli Dufva, Helena Hohtari, Sami Blom, Riku Turkki, Mette Ilander, Panu Kovanen, Celine Pallaud, Pedro Marques Ramos, Hanna Lähteenmäki, Katja Välimäki, Mohamed El Missiry, Antonio Ribeiro, Olli Kallioniemi, Kimmo Porkka, Teijo Pellinen, Satu Mustjoki
Journal: Blood Advances
Blood Adv (2020) 4 (2): 274–286.
https://doi.org/10.1182/bloodadvances.2019000792
Published: 2020
Includes: Supplemental data
Journal Articles

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP

Clinical Trials & Observations
Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso, Francesco Albano, Mario Annunziata, Sara Barulli, Germana Beltrami, Micaela Bergamaschi, Gianni Binotto, Monica Bocchia, Giovanni Caocci, Isabella Capodanno, Francesco Cavazzini, Michele Cedrone, Marco Cerrano, Monica Crugnola, Mariella D’Adda, Chiara Elena, Carmen Fava, Paola Fazi, Claudio Fozza, Sara Galimberti, Valentina Giai, Antonella Gozzini, Gabriele Gugliotta, Alessandra Iurlo, Gaetano La Barba, Luciano Levato, Alessandro Lucchesi, Luigia Luciano, Francesca Lunghi, Monia Lunghi, Michele Malagola, Roberto Marasca, Bruno Martino, Angela Melpignano, Maria Cristina Miggiano, Enrico Montefusco, Caterina Musolino, Fausto Palmieri, Patrizia Pregno, Davide Rapezzi, Giovanna Rege-Cambrin, Serena Rupoli, Marzia Salvucci, Rosaria Sancetta, Simona Sica, Raffaele Spadano, Fabio Stagno, Mario Tiribelli, Simona Tomassetti, Elena Trabacchi, Massimiliano Bonifacio, Massimo Breccia, Fausto Castagnetti, Fabrizio Pane, Domenico Russo, Giuseppe Saglio, Simona Soverini, Paolo Vigneri, Gianantonio Rosti
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4280–4290.
https://doi.org/10.1182/bloodadvances.2019000865
Published: 2019
Journal Articles

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Clinical Trials & Observations
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Miyuki Sugimoto, Yuko Ishihara, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Shin-ichiro Fujiwara, Masuzu Ueda, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3266–3277.
https://doi.org/10.1182/bloodadvances.2019000745
Published: 2019
Includes: Supplemental data
Journal Articles

Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib

Clinical Trials & Observations
Chung H. Kok, David T. Yeung, Liu Lu, Dale B. Watkins, Tamara M. Leclercq, Phuong Dang, Verity A. Saunders, John Reynolds, Deborah L. White, Timothy P. Hughes
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1610–1621.
https://doi.org/10.1182/bloodadvances.2019000195
Published: 2019
Includes: Supplemental data
Journal Articles

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia

Clinical Trials & Observations
Adrian G. Minson, Katherine Cummins, Lucy Fox, Ben Costello, David Yeung, Rebecca Cleary, Cecily Forsyth, Maciek Tatarczuch, Kate Burbury, Olga Motorna, Jake Shortt, Shaun Fleming, Andrew McQuillan, Anthony Schwarer, Rosemary Harrup, Amy Holmes, Sumita Ratnasingam, Kah-Lok Chan, Wei-Hsun Hsu, Asma Ashraf, Faye Putt, Andrew Grigg
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1084–1091.
https://doi.org/10.1182/bloodadvances.2018028035
Published: 2019
Includes: Supplemental data
Journal Articles

Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs

Clinical Trials & Observations
Preetesh Jain, Hagop Kantarjian, Prajwal C. Boddu, Graciela M. Nogueras-González, Srdan Verstovsek, Guillermo Garcia-Manero, Gautam Borthakur, Koji Sasaki, Tapan M. Kadia, Princy Sam, Hycienth Ahaneku, Susan O’Brien, Zeev Estrov, Farhad Ravandi, Elias Jabbour, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2019) 3 (6): 851–861.
https://doi.org/10.1182/bloodadvances.2018025874
Published: 2019
Includes: Supplemental data
Journal Articles

C/EBPβ is a critical mediator of IFN-α–induced exhaustion of chronic myeloid leukemia stem cells

Asumi Yokota, Hideyo Hirai, Ryuichi Sato, Hiroko Adachi, Fumiko Sato, Yoshihiro Hayashi, Atsushi Sato, Naoka Kamio, Yasuo Miura, Masakazu Nakano, Daniel G . Tenen, Shinya Kimura, Kei Tashiro, Taira Maekawa
Journal: Blood Advances
Blood Adv (2019) 3 (3): 476–488.
https://doi.org/10.1182/bloodadvances.2018020503
Published: 2019
Includes: Supplemental data
Journal Articles

Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation

Clinical Trials & Observations
Koichi Miyamura, Kazunori Ohnishi, Shigeki Ohtake, Noriko Usui, Chiaki Nakaseko, Hiroyuki Fujita, Shin Fujisawa, Toru Sakura, Hirokazu Okumura, Noriyoshi Iriyama, Nobuhiko Emi, Katsumichi Fujimaki, Sumihisa Honda, Yasushi Miyazaki, Tomoki Naoe
Journal: Blood Advances
Blood Adv (2019) 3 (3): 312–319.
https://doi.org/10.1182/bloodadvances.2018025981
Published: 2019
Includes: Supplemental data
Journal Articles

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, Sandeep Jain, Amer Assal, Jan Cerny, Edward A. Copelan, Andrew Daly, Zachariah DeFilipp, Shahinaz M. Gadalla, Robert Peter Gale, Siddhartha Ganguly, Betty K. Hamilton, Gerhard Carl Hildebrandt, Jack W. Hsu, Yoshihiro Inamoto, Abraham S. Kanate, H. Jean Khoury, Hillard M. Lazarus, Mark R. Litzow, Sunita Nathan, Richard F. Olsson, Attaphol Pawarode, Olle Ringden, Jacob M. Rowe, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sachiko Seo, Nirav N. Shah, Melhem Solh, Robert K. Stuart, Celalettin Ustun, Ann E. Woolfrey, Jean A. Yared, Edwin P. Alyea, Matt E. Kalaycio, Uday Popat, Ronald M. Sobecks, Wael Saber
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2922–2936.
https://doi.org/10.1182/bloodadvances.2018024844
Published: 2018
Includes: Supplemental data
Journal Articles

Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia

Anne-Sophie Bouillon, Monica S. Ventura Ferreira, Shady Adnan Awad, Johan Richter, Andreas Hochhaus, Volker Kunzmann, Jolanta Dengler, Jeroen Janssen, Gert Ossenkoppele, Peter E. Westerweel, Peter A. W. te Boekhorst, Francois-Xavier Mahon, Henrik Hjorth-Hansen, Susanne Isfort, Thoas Fioretos, Sebastian Hummel, Mirle Schemionek, Stefan Wilop, Steffen Koschmieder, Susanne Saußele, Satu Mustjoki, Fabian Beier, Tim H. Brümmendorf
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1572–1579.
https://doi.org/10.1182/bloodadvances.2018017772
Published: 2018
Includes: Supplemental data
Journal Articles

Providing molecular diagnosis and monitoring of patients with chronic myeloid leukemia in Abuja, Nigeria

Chi-kadibia Ukoma, Oche P. Ogbe, Ekaette David, T. T. Wakama, Nicola Evans, Jane Apperley
Journal: Blood Advances
Blood Adv (2017) 1 (Suppl): 29–31.
https://doi.org/10.1182/bloodadvances.2017GS102032
Published: 2017
Journal Articles

Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy

Clinical Trials & Observations
Zimu Gong, L. Jeffrey Medeiros, Jorge E. Cortes, Zi Chen, Lan Zheng, Yan Li, Shi Bai, Pei Lin, Roberto N. Miranda, Jeffrey L. Jorgensen, Timothy J. McDonnell, Wei Wang, Hagop M. Kantarjian, Shimin Hu
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2541–2552.
https://doi.org/10.1182/bloodadvances.2017011858
Published: 2017
Includes: Supplemental data
Journal Articles

Maintenance of telomere length in AML

Peter M. Lansdorp
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2467–2472.
https://doi.org/10.1182/bloodadvances.2017012112
Published: 2017
Journal Articles

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

Clinical Trials & Observations
Lucy C. Fox, Katherine D. Cummins, Ben Costello, David Yeung, Rebecca Cleary, Cecily Forsyth, Maciek Tatarczuch, Kate Burbury, Olga Motorna, Jake Shortt, Shaun Fleming, Andrew McQuillan, Anthony Schwarer, Rosemary Harrup, Amy Holmes, Sumita Ratnasingam, Kah-Lok Chan, Wei-Hsun Hsu, Asma Ashraf, Faye Putt, Andrew Grigg
Journal: Blood Advances
Blood Adv (2017) 1 (13): 802–811.
https://doi.org/10.1182/bloodadvances.2016003889
Published: 2017
Journal Articles

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia

Ross Kinstrie, Dimitris Karamitros, Nicolas Goardon, Heather Morrison, Mike Hamblin, Lisa Robinson, Richard E. Clark, Mhairi Copland, Paresh Vyas
Journal: Blood Advances
Blood Adv (2016) 1 (3): 160–169.
https://doi.org/10.1182/bloodadvances.2016000810
Published: 2016
Includes: Supplemental data